These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 16974207

  • 1. Sustained effects of phenelzine and tranylcypromine on orthostatic challenge in antidepressant-refractory depression.
    Tulen JH, Volkers AC, van den Broek WW, Bruijn JA.
    J Clin Psychopharmacol; 2006 Oct; 26(5):542-4. PubMed ID: 16974207
    [No Abstract] [Full Text] [Related]

  • 2. Effects of imipramine, fluvoxamine and depressive mood on autonomic cardiac functioning in major depressive disorder.
    Volkers AC, Tulen JH, van den Broek WW, Bruyn JA, Passchier J, Pepplinkhuizen L.
    Pharmacopsychiatry; 2004 Jan; 37(1):18-25. PubMed ID: 14750044
    [Abstract] [Full Text] [Related]

  • 3. Not all monoamine oxidase inhibitors are created equal.
    Stewart JT.
    J Am Geriatr Soc; 2007 Nov; 55(11):1890. PubMed ID: 17979910
    [No Abstract] [Full Text] [Related]

  • 4. Continuation and maintenance treatments in major depression: the neglected role of monoamine oxidase inhibitors.
    Kennedy SH.
    J Psychiatry Neurosci; 1997 Mar; 22(2):127-31. PubMed ID: 9074307
    [Abstract] [Full Text] [Related]

  • 5. Orthostatic hypotension and antidepressant pharmacotherapy.
    Tesar GE, Rosenbaum JF, Biederman J, Weilburg JB, Pollack MH, Gross CC, Falk WE, Gastfriend DR, Zusky PM, Bouckoms A.
    Psychopharmacol Bull; 1987 Mar; 23(1):182-6. PubMed ID: 3602317
    [No Abstract] [Full Text] [Related]

  • 6. Adverse reactions to monoamine oxidase inhibitors. Part I. A comparative study.
    Rabkin J, Quitkin F, Harrison W, Tricamo E, McGrath P.
    J Clin Psychopharmacol; 1984 Oct; 4(5):270-8. PubMed ID: 6386898
    [Abstract] [Full Text] [Related]

  • 7. Differential response patterns to MAO inhibitors and tricyclics.
    Nies A.
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
    [Abstract] [Full Text] [Related]

  • 8. A comparative study of the efficacy and safety profiles between fluvoxamine and nortriptyline in Japanese patients with major depression.
    Otsubo T, Akimoto Y, Yamada H, Koda R, Aoyama H, Tanaka K, Mimura M, Nakagome K, Kamijima K.
    Pharmacopsychiatry; 2005 Jan; 38(1):30-5. PubMed ID: 15706464
    [Abstract] [Full Text] [Related]

  • 9. Safety of high-intensity treatment with the irreversible monoamine oxidase inhibitor tranylcypromine in patients with treatment-resistant depression.
    Adli M, Pilhatsch M, Bauer M, Köberle U, Ricken R, Janssen G, Ulrich S, Bschor T.
    Pharmacopsychiatry; 2008 Nov; 41(6):252-7. PubMed ID: 19067263
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of tranylcypromine versus phenelzine: a double-blind study in antidepressant-refractory depressed inpatients.
    Birkenhäger TK, van den Broek WW, Mulder PG, Bruijn JA, Moleman P.
    J Clin Psychiatry; 2004 Nov; 65(11):1505-10. PubMed ID: 15554763
    [Abstract] [Full Text] [Related]

  • 11. Columbia atypical depression. A subgroup of depressives with better response to MAOI than to tricyclic antidepressants or placebo.
    Quitkin FM, Stewart JW, McGrath PJ, Tricamo E, Rabkin JG, Ocepek-Welikson K, Nunes E, Harrison W, Klein DF.
    Br J Psychiatry Suppl; 1993 Sep; (21):30-4. PubMed ID: 8217065
    [Abstract] [Full Text] [Related]

  • 12. Treatment response of depressed outpatients unresponsive to both a tricyclic and a monoamine oxidase inhibitor antidepressant.
    McGrath PJ, Stewart JW, Nunes EN, Quitkin FM.
    J Clin Psychiatry; 1994 Aug; 55(8):336-9. PubMed ID: 8071301
    [Abstract] [Full Text] [Related]

  • 13. Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.
    McGrath PJ, Stewart JW, Fava M, Trivedi MH, Wisniewski SR, Nierenberg AA, Thase ME, Davis L, Biggs MM, Shores-Wilson K, Luther JF, Niederehe G, Warden D, Rush AJ.
    Am J Psychiatry; 2006 Sep; 163(9):1531-41; quiz 1666. PubMed ID: 16946177
    [Abstract] [Full Text] [Related]

  • 14. L-tryptophan in depression.
    Farkas T, Dunner DL, Fieve RR.
    Biol Psychiatry; 1976 Jun; 11(3):295-302. PubMed ID: 779855
    [Abstract] [Full Text] [Related]

  • 15. Limitation and potential hazards of MAOI's for the treatment of depressive symptoms in abstinent alcoholics.
    Schottenfeld RS, O'Malley SS, Smith L, Rounsaville BJ, Jaffe JH.
    Am J Drug Alcohol Abuse; 1989 Jun; 15(3):339-44. PubMed ID: 2669469
    [No Abstract] [Full Text] [Related]

  • 16. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
    Birkenhäger TK, van den Broek WW, Fekkes D, Mulder PG, Moleman P, Bruijn JA.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1084-8. PubMed ID: 17467132
    [Abstract] [Full Text] [Related]

  • 17. Refractory depression treated with high doses of monoamine oxidase inhibitor.
    Guze BH, Baxter LR, Rego J.
    J Clin Psychiatry; 1987 Jan 30; 48(1):31-2. PubMed ID: 3804984
    [Abstract] [Full Text] [Related]

  • 18. A placebo-controlled comparison of the effect of nortriptyline and phenelzine on orthostatic hypotension in elderly depressed patients.
    Georgotas A, McCue RE, Friedman E, Cooper TB.
    J Clin Psychopharmacol; 1987 Dec 30; 7(6):413-6. PubMed ID: 3323263
    [Abstract] [Full Text] [Related]

  • 19. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management.
    Rabkin JG, Quitkin FM, McGrath P, Harrison W, Tricamo E.
    J Clin Psychopharmacol; 1985 Feb 30; 5(1):2-9. PubMed ID: 3973068
    [Abstract] [Full Text] [Related]

  • 20. [Abuse of the monoamine oxidase (MAOI) inhibitors as antidepressive drugs: a critical review].
    García-Campayo JJ, Sanz-Carrillo C, Ferrández Payo M.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1995 Feb 30; 23(4):217-22. PubMed ID: 7484306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.